Skip to Content


Lung Map Study

Lung Map Study


Phase II/III biomarker-driven master protocol for second line therapy of Squamous Cell Lung Cancer. "Lung-Map" is short for "lung cancer master protocol." The purpose of the Lung-Map Study is to compare the effects, good and bad, of investgational drugs targeted at specific genetic changes found in a patient's lung cancer tumor to the usual approach for treating this type of tumor. To be better than the usual treatment, a study drug should lengthen the average time to cancer worsening by more than a month.

Clinical Trial Categories

  • Oncology
Research Study Staff at 425-688-5407


  • Overlake Medical Center
    1035 116th Ave. NE
    Bellevue, WA 98004
    Main: 425-688-5000